Category

Press Release

An Exciting Breakthrough in Liver Cell Therapy

Likarda Announces Peer-Reviewed Publication Highlighting Hydrogel Encapsulation with CSS Can Overcome Major Obstacle of Liver Cell Therapies Likarda’s proprietary Core-Shell Spherification® (CSS®) technology improved long-term performance of transplanted liver cells...

Likarda appoints Shelly Adams as Chief Commercial Officer

Kansas City, USA, April 17, 2024 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, today announces the appointment of Shelly Adams as Chief Commercial...

Likarda and Evia Bio Announce Novel Tech Cryo Partnership

Kansas City, MO, October 10, 2023 – Likarda, a leader in cell therapy encapsulation for delivery and Evia Bio, a life sciences innovation company that develops non-DMSO cryopreservation solutions, announced today a strategic partnership to deliver better and safer...

Likarda and eQcell Announce License Option Agreement

Likarda’s Custom Hydrogel Encapsulant to be Used as Cell Therapy Delivery System to Treat Equine Lameness Cambridge, Massachusetts, February 17, 2022 – Likarda, LLC is a cell therapy company developing innovative delivery systems to optimize cell therapies. Their...

Search

Categories

Don't miss out on new resources!

Get our monthly newsletter